Mallinckrodt Pharmaceuticals Signs Distribution Agreement with Amneal Pharmaceuticals LLC

Mallinckrodt announced today that it has entered into an agreement with Amneal Pharmaceuticals LLC to distribute to addiction treatment centers its Buprenorphine HCl and Naloxone HCl Dihydrate Sublingual Tablets (CIII), a generic version of Suboxone®, manufactured in Amneal’s Hauppauge, New York, facility.

Source: – August 20, 2013